HopeStage
Back to all studies
CompletedEUCTR 2012-003404-12

Pharmacokinetics and safety of agomelatine in children (from 7 to less than 12 years) and adolescents (from 12 to less than 18 years) with Depressive or Anxiety Disorder. An open-labelled, multice...

This historical record does not confirm current site availability.

Historical research recordMultiple countries
The study in practice

Understand this study

What did researchers investigate?

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.

Listed locations
Estonia · Finland and 4 more locations
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateNot clearly listed
Recruitment status
Completed
Enrollment listed in the registry
48
Sponsor
Institut de Recherches Internationales Servier
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Estonia, Finland, Hungary, ...
Age range
Not clearly listed
Official registry ID
EUCTR 2012-003404-12
Official title
Show the full official title

Pharmacokinetics and safety of agomelatine in children (from 7 to less than 12 years) and adolescents (from 12 to less than 18 years) with Depressive or Anxiety Disorder. An open-labelled, multice...

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Estonia · Finland · Hungary

3 more locations
  • Poland
  • Romania
  • Sweden
Registry details
Historical country statuses

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Institut de Recherches Internationales Servier, a research institute.

Want to explore more studies?

Explore studies